Advertisement

Topics

US Approvals Analysis: Original PMA Slowdown, De Novo Upswing Among Recent Trends

00:01 EST 13 Nov 2017 | SCRIP

The volume of original PMAs coming to US FDA for review is down recently, while panel-track supplement, de novo and...

      

Related Stories

 

Original Article: US Approvals Analysis: Original PMA Slowdown, De Novo Upswing Among Recent Trends

NEXT ARTICLE

More From BioPortfolio on "US Approvals Analysis: Original PMA Slowdown, De Novo Upswing Among Recent Trends"

Advertisement
Quick Search
Advertisement
Advertisement